chloroquine has been researched along with amantadine in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (17.78) | 18.7374 |
1990's | 12 (26.67) | 18.2507 |
2000's | 13 (28.89) | 29.6817 |
2010's | 11 (24.44) | 24.3611 |
2020's | 1 (2.22) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Balzarini, J; Bharatam, PV; Chibale, K; Kaur, H; Little, S; Singh, K | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Balzarini, J; Chibale, K; Kaur, H; Singh, K | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Batta, G; Borbás, A; Csávás, M; Herczegh, P; Kelemen, V; Le Thai, S; Naesens, L; Rőth, E; Stevaert, A; Szűcs, Z; Vanderlinden, E | 1 |
Benoliel, AM; Bongrand, P; Maurin, M; Raoult, D | 1 |
Spear, PG; Wittels, M | 1 |
Henk, WG; Payne, HR; Storz, J | 1 |
Anderson, SK; DeSantes, K; Geissler, F; Press, OW | 1 |
Fukuhara, N; Ishida, N; Kitaoka, S; Konno, T; Yoshie, O | 1 |
Glushakova, SE; Lukashevich, IS | 1 |
Hortin, G; Strauss, AW | 1 |
Kagan, BL | 1 |
Brown, DT; Cassell, S; Edwards, J | 1 |
Griffiths, N; Lamb, JF; Ogden, P | 1 |
Helenius, A; Marsh, M; White, J | 1 |
Hostetler, KY; Richman, DD | 1 |
Carrasco, L; Pérez, L | 2 |
Evans, SG; Havlik, I | 2 |
Everitt, E; Rodríguez, E | 2 |
Cubitt, B; de la Torre, JC; Gonzalez-Dunia, D | 1 |
McCullough, KC; Natale, VA | 1 |
Fredericksen, BL; Garcia, JV; Luo, T; Wei, BL; Yao, J | 1 |
Bray, PG; Fidock, DA; Johnson, DJ; Lakshmanan, V; Mungthin, M; Sidhu, AB; Ward, SA | 1 |
Wellems, TE | 1 |
Steffen, AC; Sundberg, AL | 1 |
Baker, ES; Lehane, AM; Martin, RE; Nash, MN; Richards, SN; Shafik, SH; Webster, MW | 1 |
Casimiro, F; da Mata, GF; Fernandes, DE; Gomes, CP; Mastroianni-Kirsztajn, G; Passos, MT; Pesquero, JB; Varela, P | 1 |
2 review(s) available for chloroquine and amantadine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics.
Topics: Acute Kidney Injury; Amantadine; Angiotensin-Converting Enzyme 2; Cathepsin L; Chloroquine; COVID-19; COVID-19 Drug Treatment; Cysteine Proteinase Inhibitors; Genetic Predisposition to Disease; Heparin; Humans; Hydroxychloroquine; Lysosomes; Molecular Targeted Therapy; Pandemics; Receptors, Virus; Respiratory Distress Syndrome; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Teicoplanin; Virus Internalization | 2020 |
43 other study(ies) available for chloroquine and amantadine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure-activity relationship and mode of action studies.
Topics: Aminoquinolines; Animals; Antimalarials; Cell Line; DNA; Dogs; Heme; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Plasmodium falciparum; Protoporphyrins; Pyrimidines; Structure-Activity Relationship; Viruses | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Synthesis of 4-aminoquinoline-pyrimidine hybrids as potent antimalarials and their mode of action studies.
Topics: Antimalarials; Antiviral Agents; Cell Line; Chemistry Techniques, Synthetic; DNA; Heme; Humans; Plasmodium falciparum; Pyrimidines; Structure-Activity Relationship | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents.
Topics: Antiviral Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Influenza A virus; Influenza B virus; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Teicoplanin | 2018 |
Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm.
Topics: Amantadine; Ammonium Chloride; Animals; Anti-Bacterial Agents; Cell Line; Chloroquine; Coxiella burnetii; Doxycycline; Hydrogen-Ion Concentration; Lysosomes; Macrophages; Mice; Pefloxacin; Phagocytosis; Rifampin | 1992 |
Penetration of cells by herpes simplex virus does not require a low pH-dependent endocytic pathway.
Topics: Adsorption; Amantadine; Animals; Chloroquine; Colchicine; Concanavalin A; Cytochalasin B; Dithiothreitol; Endocytosis; Heparin; Hydrogen-Ion Concentration; Microscopy, Electron; Monensin; Simplexvirus; Trifluoperazine; Tumor Cells, Cultured; Vero Cells; Vesicular stomatitis Indiana virus; Viral Plaque Assay; Wheat Germ Agglutinins | 1991 |
Initial events in bovine coronavirus infection: analysis through immunogold probes and lysosomotropic inhibitors.
Topics: Adsorption; Amantadine; Ammonium Chloride; Antigens, Viral; Chloroquine; Coronaviridae; Coronaviridae Infections; Endocytosis; Humans; Immunohistochemistry; Methylamines; Microscopy, Immunoelectron; Temperature; Time Factors; Tumor Cells, Cultured; Viral Plaque Assay | 1990 |
Inhibition of catabolism of radiolabeled antibodies by tumor cells using lysosomotropic amines and carboxylic ionophores.
Topics: Acid Phosphatase; Amantadine; Ammonium Chloride; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Chloroquine; Chromatography, High Pressure Liquid; Humans; Iodine Radioisotopes; Lysosomes; Mice; Monensin; Nigericin; Temperature; Tumor Cells, Cultured; Verapamil | 1990 |
Evidence for endocytosis-independent infection by human rotavirus.
Topics: Amantadine; Ammonium Chloride; Animals; Cadaverine; Cell Line; Chloroquine; Cytochalasin B; Endocytosis; Haplorhini; Hydrogen-Ion Concentration; Lysosomes; Methylamines; Rotavirus; Vesicular stomatitis Indiana virus; Virus Replication | 1987 |
Early events in arenavirus replication are sensitive to lysosomotropic compounds.
Topics: Adsorption; Amantadine; Ammonium Chloride; Antiviral Agents; Arenaviridae; Chloroquine; Lassa virus; Monensin; Virus Replication | 1989 |
Effects of acidotropic compounds on the secretory pathway: inhibition of secretion and processing of the third and fourth components of complement.
Topics: Amantadine; Benzamidines; Carcinoma, Hepatocellular; Cell Line; Chloroquine; Complement C3; Complement C4; Cyclohexylamines; Electrophoresis, Polyacrylamide Gel; Ethylamines; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Lysosomes; Protein Precursors; Protein Processing, Post-Translational | 1986 |
Lysosomotropic agents in AIDS treatment.
Topics: Acquired Immunodeficiency Syndrome; Amantadine; Chloroquine; Humans | 1987 |
Effects of lysosomotropic weak bases on infection of BHK-21 cells by Sindbis virus.
Topics: Amantadine; Ammonium Chloride; Animals; Cell Line; Chloroquine; Cricetinae; Endocytosis; Kidney; Lysosomes; RNA, Viral; Sindbis Virus; Virus Replication | 1984 |
The effects of chloroquine and other weak bases on the accumulation and efflux of digoxin and ouabain in HeLa cells.
Topics: Amantadine; Biological Transport, Active; Chloroquine; Cycloheximide; Digoxin; HeLa Cells; Humans; Ouabain; Potassium; Sodium | 1983 |
Inhibition of Semliki forest virus penetration by lysosomotropic weak bases.
Topics: Amantadine; Ammonium Chloride; Animals; Butylamines; Cell Fusion; Cell Line; Chloroquine; Cricetinae; Endocytosis; Lysosomes; Mesocricetus; Methylamines; Receptors, Virus; RNA, Viral; Semliki forest virus | 1982 |
Studies on the mechanism of phospholipid storage induced by amantadine and chloroquine in Madin Darby canine kidney cells.
Topics: Amantadine; Ammonium Chloride; Animals; Cells, Cultured; Chloroquine; Dogs; Kidney; Liver; Lysosomes; Phospholipases A; Phospholipids; Subcellular Fractions; Type C Phospholipases | 1982 |
Involvement of the vacuolar H(+)-ATPase in animal virus entry.
Topics: Amantadine; Animals; Anti-Bacterial Agents; Cadaverine; Cell Line; Chloroquine; Cricetinae; DNA Viruses; Electrophoresis, Polyacrylamide Gel; Endocytosis; HeLa Cells; Humans; Kidney; Macrolides; Methionine; Monensin; Proton-Translocating ATPases; Receptors, Virus; RNA Viruses; Semliki forest virus; Vacuoles; Viral Proteins | 1994 |
Entry of poliovirus into cells does not require a low-pH step.
Topics: Amantadine; Animals; Anti-Bacterial Agents; Autoradiography; Cadaverine; Cell Line; Chloroquine; Electrophoresis, Polyacrylamide Gel; HeLa Cells; Humans; Hydrogen-Ion Concentration; Macrolides; Methionine; Models, Biological; Monensin; Poliovirus; Proton-Translocating ATPases; Semliki forest virus; Sulfur Radioisotopes; Vesicular stomatitis Indiana virus; Viral Proteins; Virus Replication | 1993 |
Plasmodium falciparum: effects of amantadine, an antiviral, on chloroquine-resistant and -sensitive parasites in vitro and its influence on chloroquine activity.
Topics: Amantadine; Animals; Antimalarials; Chloroquine; Drug Resistance; Drug Synergism; Microbial Sensitivity Tests; Plasmodium falciparum | 1993 |
Effect of pH on in vitro potency of amantadine against Plasmodium falciparum.
Topics: Adamantane; Amantadine; Ammonium Chloride; Animals; Antimalarials; Chloroquine; Culture Media; Dose-Response Relationship, Drug; Drug Resistance; Humans; Hydrogen-Ion Concentration; Mefloquine; Plasmodium falciparum; Quinine | 1996 |
Adenovirus uncoating and nuclear establishment are not affected by weak base amines.
Topics: Adenoviridae; Amantadine; Ammonium Chloride; Chloroquine; HeLa Cells; Humans; Hydrogen-Ion Concentration; Methylamines; Transcription, Genetic; Virus Replication | 1996 |
Mechanism of Borna disease virus entry into cells.
Topics: Amantadine; Ammonium Chloride; Animals; Borna disease virus; Cell Line; Chloroquine; Cytopathogenic Effect, Viral; Endocytosis; Giant Cells; Hydrogen-Ion Concentration; Lysosomes; Membrane Fusion; Rats; Transcription, Genetic; Viral Proteins; Virus Replication | 1998 |
Macrophage cytoplasmic vesicle pH gradients and vacuolar H+-ATPase activities relative to virus infection.
Topics: Acridine Orange; African Swine Fever; African Swine Fever Virus; Amantadine; Animals; Anti-Bacterial Agents; Antiviral Agents; Cells, Cultured; Chloroquine; Cytoplasm; Enzyme Inhibitors; Female; Fluorescein-5-isothiocyanate; Hydrogen-Ion Concentration; Lysosomes; Macrolides; Macrophages; Male; Proton Pump Inhibitors; Proton Pumps; Proton-Translocating ATPases; Swine; Vacuoles; Virus Replication; Zymosan | 1998 |
Adenovirus cellular receptor site recirculation of HeLa cells upon receptor-mediated endocytosis is not low pH-dependent.
Topics: Adenoviruses, Human; Amantadine; Ammonium Chloride; Chloroquine; Cycloheximide; Endocytosis; HeLa Cells; Humans; Hydrogen-Ion Concentration; Kinetics; Methionine; Monensin; Nigericin; Receptors, Virus; Sulfur Radioisotopes | 1999 |
Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus.
Topics: Amantadine; Animals; Anti-Bacterial Agents; Cell Line; Chloroquine; Endocytosis; Endosomes; HeLa Cells; HIV Long Terminal Repeat; HIV-1; Humans; Hydrogen-Ion Concentration; Leukemia Virus, Murine; Lysosomes; Macrolides; Mice; Transduction, Genetic | 2002 |
Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents.
Topics: Alanine; Alleles; Amantadine; Amino Acid Sequence; Amino Acid Substitution; Animals; Antimalarials; Chloroquine; Drug Resistance, Multiple; Genes, Protozoan; Haplotypes; Hemin; Membrane Proteins; Membrane Transport Proteins; Microsatellite Repeats; Molecular Sequence Data; Parasitic Sensitivity Tests; Phenanthrenes; Plasmodium falciparum; Point Mutation; Protein Structure, Secondary; Protozoan Proteins; Recombination, Genetic; Verapamil | 2004 |
Transporter of a malaria catastrophe.
Topics: Amantadine; Animals; Chloroquine; Drug Resistance; Global Health; Humans; Malaria, Falciparum; Membrane Proteins; Membrane Transport Proteins; Models, Biological; Mutation; Plasmodium falciparum; Protozoan Proteins | 2004 |
Enhancing the effect of radionuclide tumor targeting, using lysosomotropic weak bases.
Topics: Amantadine; Ammonium Chloride; Antimalarials; Antipsychotic Agents; Antiviral Agents; Astatine; Carcinoma, Squamous Cell; Cell Line, Tumor; Chloroquine; Epidermal Growth Factor; Glioma; Humans; Iodine Radioisotopes; Radioimmunotherapy; Radioisotopes; Recombinant Fusion Proteins; Thioridazine | 2007 |
Molecular Mechanisms for Drug Hypersensitivity Induced by the Malaria Parasite's Chloroquine Resistance Transporter.
Topics: Amantadine; Animals; Antimalarials; Biological Transport; Blotting, Western; Chloroquine; Drug Resistance; Fluorescent Antibody Technique; Humans; Malaria, Falciparum; Membrane Transport Proteins; Mutagenesis, Site-Directed; Plasmodium falciparum; Protein Isoforms; Protozoan Proteins; Quinine; Xenopus laevis | 2016 |